syndrome dropped from 32%/' in infants of 1000-1500 g and 8%o in infants of 1500-2500 g in 1972-44 to 21% and 2% respectively in 1978-80 (annual reports of the neonatal unit, Cambridge Maternity Hospital, 1978-80). These figures are from a reasonably well-equipped and well-staffed regional neonatal care unit, and the evidence is that results internationally are surprisingly similar.3 The national neonatal mortality rates in England and Wales for infants of low birth weight are, however, two to three times those reported from neonatal intensive care units. Many of these deaths could be prevented merely by providing adequate neonatal care facilities on a national basis.
Even in the best unit, however, where survival is the rule for infants with respiratory distress syndrome weighing more than 1250 g at birth, survival is rare in infants weighing less than 750 g at birth; and for infants weighing 750-1250 g at birth the mortality from respiratory distress syndrome remains unacceptably high at around 25-40%/.
One approach used in attempting to reduce this mortality is to try to induce production of surfactant in the lungs of the fetus about to be delivered prematurely. but not quite as effective as the centrifugated preparation when instilled into the trachea of premature rabbits. 29 The effects of replacement of surfactant in human neonates with respiratory distress syndrome have been described in two recent reports. Fujiwara et a130 instilled 10 ml of artificial surfactant (a mixture of bovine lung-wash surfactant topped up with synthetic dipalmitoyl-lecithin and phosphatidylglycerol, containing 125 mg of surfactant lipid) down the endotracheal tube in 10 infants with severe respiratory distress syndrome who were requiring intermittent positive-pressure ventilation four to 33 hours after birth. Though the respiratory distress syndrome persisted there was a noticeable improvement in arterial oxygen tension within an hour, and this was sustained in most cases. Nine of the infants, however, developed a large and symptomatic patent ductus arteriosus. Eight infants survived. Clearly, the instillation down a sick infant's endotracheal tube of a volume of fluid that is considerably greater than his tidal volume and contains large amounts of heterologous animal protein is a procedure not to be undertaken lightly. The approach of Morley's group,3 using a protein-free synthetic surfactant, is therefore much more acceptable clinically. 
